Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas
Transplantation and Cellular Therapy · 2026-11 · 32 (11) · 1419.e1-1419.e4
DOI: 10.1016/j.jtct.2026.06.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation and Cellular Therapy, 2026-11. Verfasst von Niveen Shibli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine,…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
- Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Cente…
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York.
- Department of Hematology, Soroka University Medical Center and Faculty of Health and Science, Ben Gurion University of the Negev, Beer Sheva, Israel.
- Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
Zitieren
APA
Shibli, N., Einarsdottir, S., Fei, T., Shouval, R., Perales, M. A., Gomez-Llobell, M., Shah, G., Ringelstein-Harlev, S., Escribano-Serrat, S., Halloun, J., Greenbaum, U., Park, J. H., Stern, A., Zuckerman, T., Beyar-Katz, O., & Maroun, E. (2026). Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy, 32(11), 1419.e1-1419.e4. https://doi.org/10.1016/j.jtct.2026.06.044
Vancouver
Shibli N, Einarsdottir S, Fei T, Shouval R, Perales MA, Gomez-Llobell M, et al. Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy. 2026;32(11):1419.e1-1419.e4. doi:10.1016/j.jtct.2026.06.044
BibTeX
@article{Shibli2026,
author = {Shibli, Niveen and Einarsdottir, Sigrun and Fei, Teng and Shouval, Roni and Perales, Miguel-Angel and Gomez-Llobell, Marina and Shah, Gunjan and Ringelstein-Harlev, Shimrit and Escribano-Serrat, Silvia and Halloun, Jabour and Greenbaum, Uri and Park, Jae H and Stern, Anat and Zuckerman, Tsila and Beyar-Katz, Ofrat and Maroun, Elias},
title = {Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas},
journal = {Transplantation and Cellular Therapy},
year = {2026},
volume = {32},
number = {11},
pages = {1419.e1--1419.e4},
doi = {10.1016/j.jtct.2026.06.044}
}
EUVIMED